Skip to main content
Fig. 6 | Cancer & Metabolism

Fig. 6

From: Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer

Fig. 6

PEPCKi blocks lactate utilization. Relative abundance of m + 3 a pyruvate, b PEP, and c 3PG, and m + 2 d citrate, e fumarate, and f succinate were determined from Colo205 cells following incubation with 13C3 lactate and treated with PEPCKi. Relative abundance of g m + 16 palmitate and h m + 14 myristate were determined from Colo205 cells incubated with 13C3 lactate and treated with PEPCKi. Cells were incubated in reduced nutrient media with and without 10 μM PEPCKi overnight, incubated with 10 mM 13C lactate for 6 h (polar) or 16 h (non-polar), and metabolites harvested and analyzed using GC/MS. N ≥ 3 ± SD. i Colo205 and j Moser cells were treated with PEPCKi with and without lactate and cell number determined after 5 days. k Ls174T were grown as spheroids and treated with PEPCKi in the presence or absence of lactate. Images taken after 48 h. Spheroid size was measured using ImageJ. Scale bar = 50 μm. N = 3 ± SD. NS, not significant. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page